{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2910, 
        2924
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4991, 
        5014
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2786, 
        2813
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        581, 
        610
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4914, 
        4949
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2708, 
        2734
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2926, 
        2933
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2946, 
        2947
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2900, 
        2909
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3364, 
        3381
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170919125844||ORU^R01^ORU_R01|201709191258440001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-011379^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170818000000|||||||20170818000000|&Prostate, Radical Resection, Lymph Nodes, Regional Resection, PQRS Radical Prostatectomy|1770650145^^^^^^MD^^CMS^D^^^NPI||||||20170821000000|||F||||||C61^Malignant neoplasm of prostate^I10~D07.5^Carcinoma in situ of prostate^I10|1285672592&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient is \"\" identified by requisition and container label. Prostate The specimen is labeled on the requisition and container as \"prostate and pelvic lymph nodes and periprostatic fat\". Received in formalin. Weight: 77 g. Size: 6.0 cm left to right, 3.8 cm apex to base, 4.2 cm anterior to posterior. Right seminal vesicle, attached: 3.5 x 1.7 x 1.1 cm. Left seminal vesicle, attached: 3.6 x 1.9 x 0.8 cm. Right vas deferens: 3.4 x 0.6 x 0.5 cm. Left vas deferens: 3.2 x 0.6 x 0.6 cm. Prostatic surface: Tan, predominantly smooth and glistening. Inking code: Right half green, left half blue, anterior midline orange, posterior midline black, seminal vesicle tips yellow. Sectioning: Apex and bladder base shaved off to be submitted. Remaining gland sectioned into 8 slices, numbered 1-8 sequentially from apex to base. Cut surface: Tan lobular parenchyma with no discrete tumor. Section code: Representative sections, including the entire prostate gland, are submitted as follows:   1A, right apex.   1B, left apex.   1C, right base.   1D, left base.   1E, right seminal vesicle and right vas deferens margin.   1F, left seminal vesicle and left vas deferens margin.   1G, right slice 1.   1H-I, right slice 2.   1J-K, right slice 3.   1L-M, right slice 4.   1N-O, right slice 5.   1P-Q, right slice 6.   1R-S, right slice 7.   1T-U, right slice 8.   1V, left slice 1.   1W-X, left slice 2.   1Y-Z, left slice 3.   1AA-AB, left slice 4.   1AC-AD, left slice 5.   1AE-AF, left slice 6.   1AG-AH, left slice 7.   1AI-AJ, left slice 8. Also present in the container are portions of fatty tissue, 6.8 x 4.6 x up to 2.4 cm in aggregate dimensions. Sectioning and palpation reveals 9 candidate lymph nodes, up to 2.8 cm in maximum dimension. Each is totally submitted. Section summary:   1AK-AL, 1 bisected candidate lymph node.   1AM-AN, 1 bisected candidate lymph node.   1AO, 1 bisected candidate lymph node.   1AP, 1 bisected candidate lymph node.   1AQ, 1 bisected candidate lymph node.   1AR-AS, 4 candidate lymph nodes, 2 per cassette, each submitted whole. A gross photograph is taken.\n\n\nPath report.site of origin\n\nProstate, pelvic lymph nodes, periprostatic fat\n\n\nPath report.final diagnosis\n\nProstate and pelvic lymph nodes (radical prostatectomy and lymph node dissection):   Prostatic adenocarcinoma, Gleason pattern 4+3=7 (grade group 3).   Tumor is unilateral involving the left side of the gland only.   The seminal vesicles are negative.   No extraprostatic extension identified.   No lymphovascular invasion seen.   Perineural invasion is present.   The remaining gland demonstrates high-grade prostatic intraepithelial neoplasia.   All margins of resection are negative.   Nine lymph nodes free of metastasis (0/9).   Stage pT2bpN0. CANCER CHECKLIST: PROSTATE GLAND: Radical Prostatectomy 3.000.001.1000043 Prostate  Tumor Site: Prostate SPECIMEN  Procedure: Radical prostatectomy Prostate Size  Prostate Weight (g): 77grams  Prostate Size in Centimeters (cm): 6.0cm  Additional Dimension in Centimeters (cm): 3.8cm, 4.2cm TUMOR  Histologic Type: Acinar adenocarcinoma Histologic Grade  Gleason Pattern: Gleason pattern  Percentage of Pattern 4: 70%  Primary Gleason Pattern: Pattern 4  Secondary Gleason Pattern: Pattern 3  Total Gleason Score: 7  Grade Group: Grade group 3  Intraductal Carcinoma (IDC): Not identified Tumor Extent  Tumor Quantitation: Estimated percentage of prostate involved by tumor (specify %)  Estimated percentage of prostate involved by tumor (specify %): 20%  Extraprostatic Extension (EPE): Not identified  Urinary Bladder Neck Invasion: Not identified  Seminal Vesicle Invasion: Not identified Accessory Findings  Treatment Effect: No known presurgical therapy  Lymphovascular Invasion: Not Identified  Perineural Invasion: Present MARGINS  Margins: Uninvolved by invasive carcinoma LYMPH NODES  Number of Lymph Nodes Involved: None identified  Number of Lymph Nodes Examined: Specify number  Specify number: 9 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  Primary Tumor (pT): pT2b: Organ confined  Regional Lymph Nodes (pN): pN0: No positive regional nodes ADDITIONAL FINDINGS  Additional Pathologic Findings: High-grade prostatic intraepithelial neoplasia (PIN) SPECIAL STUDIES  Ancillary Studies: Specify  Specify: ERG-/PTEN+ Favorable\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Malignant neoplasm of prostate (C61)\n\n\n"
}